Bicycle therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), today announced that on february 3, 2025, the compensation committee of the company's board of directors granted to 18 new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 117,300 ordinary shares. these awards were made under bicycle therapeutics' 2024 inducement plan and approved by the compensation committee as an inducement material to the employees entering.
NDAQ Ratings Summary
NDAQ Quant Ranking